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Abstract
This research investigated the effect of co- supplementation of selenium with zinc 
on weight control and the inflammatory and oxidative status in relation to obesity. 
Male Wistar rats (N = 32) were randomly divided into four groups after induction of 
obesity model: 1) “Zn” was supplemented with zinc sulfate (15 mg/kg BW), 2) “Se” 
supplemented with selenium as sodium selenate (0.5 mg/kg BW), 3) “Zn + Se” which 
received Zn (15 mg/kg BW) + Se (0.5 mg/kg BW), and 4) “HFD” as the control group. 
The intervention was done for eight weeks. At the end of treatment, serum and tissue 
level of Zn, Se, SOD, GSH- Px, MDA, leptin, TNF- α, and IL- 6 was evaluated. Weight 
and food intake were significantly reduced in the Se group(p < .001), while in the 
Zn group, weight gain due to obesity was prevented compared to the control group 
(p = .48). There was a significant and stronger increase in SOD, GSH- Px levels and a 
remarkable decrease in MDA, leptin, TNF- α, and IL- 6 in the group receiving the com-
bination of two supplements than either alone(p < .001). Leptin had a positive corre-
lation with inflammatory factors and lipid peroxidation marker and showed an inverse 
relationship with Zn and Se levels and anti- oxidative enzymes(p < .05). The analysis 
showed the mediating role of leptin in the effects of zinc. Co- supplementation of 
selenium and zinc may have a synergistic effect in reduction of oxidative and inflam-
matory markers. Regarding the effect of zinc on inflammatory factors and lipid per-
oxidation, leptin can play a mediating role.
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1  | INTRODUC TION
The rise in the prevalence of obesity has become a global concern 
with consequences such as increased mortality and morbidity, so 
it has become a major threat for public health worldwide (Hosseini 
et al., 2017). Obesity is a complex, multistage, and preventable dis-
ease that brings with it a chronic inflammatory condition and oxida-
tive status associated with comorbidities such as type 2 diabetes, 
cardiovascular disease, hypertension, and chronic kidney disease 
(Kotsis et al., 2010). In pathological obesity, adipose tissue undergoes 
a process called “adipose tissue regeneration,” which is character-
ized by increased levels of immune cell infiltration including inter-
leukin- 6 (IL- 6), tumor necrosis factor- alpha (TNF- α), and leptin and 
eventually causes chronic low- grade inflammation (Sun et al., 2011). 
On the other hand, recent evidence indicates that excess body fat 
may enhance oxidative stress, and concentrations of circulating anti-
oxidants are inversely related to body mass index (BMI). In contrast, 
lower than normal levels of some antioxidants may be linked with 
increased fat deposition in the body so oxidative stress is associated 
with the spread of obesity (Hosseini et al., 2017; Wang et al., 2010). 
Thus, antioxidants can protect cells from oxidative stress and its 
consequences by trapping free radicals.
Zinc (Zn) is the most common microelements in the human 
body and plays an important role in growth and development (Hara 
et al., 2017). This metal participates in the regulation of chronic in-
flammatory status by reducing inflammatory cytokines. It also re-
duces oxidative stress by participating in the synthesis of antioxidant 
enzymes such as superoxide dismutase and glutathione peroxidase. 
Therefore, it acts as a catalyst for enzymes and is involved in lipid, 
carbohydrate, and protein metabolism (Ahn et al., 2014; Motamed 
et al., 2013). Epidemiological studies show that low Zn intake and 
low Zn blood concentrations are associated with an increased 
prevalence of obesity (Atkinson et al., 1978; Hosseini et al., 2017). 
Moreover, obese subjects frequently have hypozincemia and hyper-
zincuria (Chen et al., 1997, 1998).
Also, zinc may play a regulatory role in serum leptin concentra-
tion and appetite control (Mantzoros et al., 1998). Leptin is an adi-
posity signal that is secreted by the adipocytes in proportion to the 
amount of body fat. In healthy people, it regulates the energy bal-
ance by increasing energy expenditure and reducing energy intake 
(Chan et al., 2003). In diet- induced obesity, leptin levels increase 
owing to leptin resistance, a condition deriving from activation of an 
inflammatory pathway, and systemic oxidative stress, and involved 
in disorders related to obesity and inflammation (Leon- Cabrera 
et al., 2013). The results of the Baltaci and Mogulkoc study suggest 
that there is a complex association between zinc and leptin in terms 
of food intake regulation and cellular immune response, and zinc may 
play an important role in regulating the effects of the leptin hormone 
(Baltaci & Mogulkoc, 2012).
Besides zinc, selenium (Se) as an antioxidant plays a key role in the 
metabolism of thyroid hormones, redox reactions, reproduction, and 
immune function in the human body (Rayman, 2000). Selenium has 
beneficial effects on antioxidant, cancer prevention, diabetes, and 
metabolic syndrome (Chen et al., 2015; Volp et al., 2010). According 
to cross- sectional studies, obesity is associated with low serum se-
lenium levels and low intake of this nutrient (Kimmons et al., 2006; 
Wang et al., 2016). Several studies found blood concentrations of se-
lenium (Se) inversely correlated with obesity, making Se deficiency a 
possible marker of adiposity (Bjørklund & Chirumbolo, 2017; Donma 
& Donma, 2016).
Taken together, a survey of the literature suggests a potential 
and promising role for Se or Zn supplementation in obesity and 
obesity- related complications. Based on our knowledge, up to now, 
there has not been a report on the effect of combined selenium and 
zinc intervention on obesity caused by high- fat diet, so we have hy-
pothesized that supplementation of selenium with zinc, as a poten-
tial nutraceutical, may reduce weight and alleviate the inflammatory 
and oxidative status in relation to obesity. Furthermore, we aimed 
to examine whether Se and Zn could exert some of their effects 
through leptin increments.
2  | MATERIAL S & METHODS
2.1 | Animals and treatment
A total of 40 male Wistar rats which were obtained from the Royan 
Institute (Tehran, Iran) at 4 weeks of age and weight of 50– 70 g 
were housed separately in stainless steel cages in a well- ventilated 
room maintained at 25 ± 2°C, with 12- hr light/12- hr dark cycles and 
50%– 55% relative humidity in the animal care facility at the National 
Nutrition and Food Technology Research Institute. Animals were 
given free access to a standard diet of commercial rat chow and tap 
water for 1 week. All animal experimental procedures were per-
formed according to National Institutes of Health (NIH) guidelines 
for the care and use of laboratory animals. This study was approved 
by the Ethics Committee of the Iran University of Medical Science 
[IR.IUMS.REC.1397.577].
Following one- week acclimatization, rats were randomly divided 
into high- fat (n = 32) and normal (n = 8) groups. The standard diet 
given to the normal group had a caloric content of 3.5 kcal/g (65% 
carbohydrates, 10% lipids, and 25% proteins). The rats in the high- fat 
group received HFD which had a caloric content of 5.6 kcal/g (20% 
carbohydrates, 20% proteins, and 60% lipids). HFD was prepared by 
Royan Institute for Biotechnology. The composition of HFD and ND 
is shown in Table 1.
When the weight of rats in the high- fat group was significantly 
higher than the normal group after 20 weeks (473.18 ± 35.49 g versus 
393.25 ± 22.30 g; p <.05) about 25% more than the normal group, 
an obesity model was induced and the treatment began for eight 
weeks. At the end of the 20th week, rats were randomly divided 
into four groups: “ 1) Group Zn” was supplemented with zinc sulfate 
(15 mg/kg BW), 2) “ group Se” was supplemented with selenium as 
sodium selenate ( 0.5 mg/kg BW), 3) “group Zn + Se” which received 
Zn (15 mg/kg BW) in combination with Se ( 0.5 mg/kg BW), and 4) 
“group HFD” without any intervention as the control group (Figure 1). 
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The supplementation was done for eight weeks. Administered 
doses of Zn and Se were determined according to previous studies 
based on no observed adverse effects (Kumar et al., 2014; Mousavi 
et al., 2018; Wang et al., 2012; Zeng et al., 2012). HFD, supple-
mented with determined doses of Zn and Se, was weighed and given 
to rats every day at 9:00 a.m. The amount of food intake (the amount 
of food spilled the day before - the amount left) was calculated and 
recorded daily, and the weight of the animals was measured and re-
corded weekly.
2.2 | Sample collection
At the end of treatment, after 12 hr fasting, animals were anesthe-
tized with 50 mg/kg of xylazine hydrochloride and 100 mg/kg of ket-
amine hydrochloride; then blood was collected via cardiac puncture. 
The plasma was immediately separated by low- speed centrifugation 
at 2,500 × g for 15 min at 4°C and stored at −80oC. The inguinal 
WAT were removed, rinsed with phosphate- buffered saline (PBS), 
and then tissue specimens were frozen in liquid nitrogen and stored 
at −80°C for posterior analysis.
2.3 | Biochemical analysis
2.3.1 | Determination of zinc and selenium levels
Adipose tissue (150mg) was heated in silica crucibles using an 
oven furnace at 550ºC for 24 hr, and the ash was taken up in hot 
hydrochloric acid (3 N) for Zn and Se analysis by atomic absorption 
spectrophotometer. Serum Zn level was determined by atomic ab-
sorption spectrophotometer.
2.3.2 | Determination of antioxidant 
enzymes activities
Measurement of SOD and GPX activity: SOD and GPX activity in 
serum and adipose tissue homogenate was determined using Rat 
Immunoassay kits (Bioassay Technology Laboratory (BT Lab), Inc., 
Shanghai, China) according to the manufacturer's protocols, based 
on the ELISA technique.
2.3.3 | Measurement of Lipid peroxidation
The lipid peroxidation level was measured as malondialdehyde 
(MDA), which is the end product of lipid peroxidation reacting with 
thiobarbituric acid (TBA) as a TBA reactive substance (TBARS) to 
produce a red- colored complex with a peak absorbance at 532 nm.
TA B L E  1   Composition of the experimental diets (per 1 kg)
Diets nutrients ND HFD
Casein (g/kg) 140 180
Cornstarch (g/kg) 630 50
Sucrose (g/kg) 100 10
Soy oil (g/kg) 40 40
SFA1 (g/kg) - 483
Fiber (g/kg) 50 50
Calcium 9.5 5.93
Phosphorus 6.5 4.06
As carbohydrate (%) 65 20
As fat (%) 10 60
As protein (%) 25 20
Energy (kcal/g) 3.6 5.6
Abbreviations: HFD, high- fat diet; ND, normal diet.
F I G U R E  1   Scheme of the study 
protocol
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2.3.4 | Determination of leptin and 
inflammatory markers
Enzyme- linked immunosorbent assay (ELISA) Kits were used to deter-
mine leptin (MyBioSource, Inc. San Diego, California, United States). 
The concentrations of serum TNF- α and IL- 6 were measured using 
the ELISA technique with commercially available kits (CUSABIO, Inc., 
Houston, USA) according to the manufacturer's protocols.
2.4 | Statistical analysis
All values are given as mean ± standard deviation (SD). Differences 
and significance between groups were evaluated using one- way anal-
ysis of variance (ANOVA), followed by Tukey's post hoc test analysis 
for multiple comparisons. To evaluate and compare the effect size, the 
standardized mean difference and its confidence interval were calcu-
lated. A t test was performed to compare the difference between two 
groups, and a paired t test was used for testing differences within the 
group. Correlation analysis was performed using Pearson's correlation 
coefficient. General linear model (univariate) was used for the analy-
sis of covariance. Baron and Kenny's method was used to investigate 
the mediating role of leptin in the effect of the intervention (zinc and 
selenium). The criteria for this method include the following: 1- The 
intervention has a significant effect on the considered factors, 2- the 
intervention has a significant effect on the mediator (leptin), 3- when 
leptin is considered as a covariate, the effect of the intervention on 
the assessed factors becomes weaker but remains significant (Baron 
& Kenny, 1986). All analyses were performed using STATA version 14. 
The MedCalc statistical software, version 18.0 (MedCalc Software 
Ltd, Ostend, Belgium), was used for drawing figures. Differences were 
considered to be significant at p <.05.
3  | RESULTS
3.1 | Body weight & dietary intake
We did not lose any of animals during the study, and therefore, 
the interventions and analysis were performed on all rats until the 
end. The initial body weight of rats showed no significant difference 
between groups before the administration period. After 8 weeks of 
intervention, rats in the HFD group gained about 60(4.8) gr weight 
compared to the initial weight, while in the Zn group this amount in-
creased by 6.67(8.1) gr which was approximately 12% of the weight 
gain observed in the HFD group, however, this difference between 
the two groups mentioned earlier was not statistically significant 
(p =0.488). The supplementation with Se and the combination of 
Zn and Se caused a significant decrease of about 53.40(12.3) gr and 
45.62(11.8) gr, respectively, compared to the HFD group (p <.001). 
The results of weight changes in groups at the end of the intervention 
remained unchanged even after adjustment for baselines (Table 2). 
Weight loss due to Se administration was statistically substantial 
(p =.018) compared to changes due to Zn supplementation lonely 
but there was no considerable difference with the Se + Zn group 
(p =.992). Also, weight changes between the combination group and 
the Zn group were not significant (p =.075) (Figure 2).
Based on the results obtained from multiple comparisons of re-
peated measures ANOVA method, in the Se and the Se + Zn groups, 
both within- group differences compared to the initial values and 
between- group comparisons versus the control group at specific 
time points were significant (Se: p˂0.001, Se + Zn: p˂0.05). This was 
not the case with the zinc group (Figure 2).
The daily dietary intake of the rats has no meaningful differences 
among groups at the beginning and the end of intervention with 
multiple comparisons of the one- way ANOVA method. However, 
considering the baseline intake as covariates of the final values and 
adjusting it, the daily food intake in the Se group showed a signifi-
cant decrease compared to the HFD group (p =.001), Zn + Se group 
(p˂0.001), and Zn group (p =.001).
3.2 | Assessment of zinc and selenium content in 
serum and WAT
The obtained data demonstrated a significant increase in zinc con-
centration in serum and adipose tissue as a result of oral supple-
mentation for 8 weeks in the Zn and Zn + Se groups comparing with 
HFD (p˂0.05). Serum level of selenium was increased in all three in-
tervention groups that were significant compared to the control [Zn 
(p =.024), Se (p˂0.001), Zn + Se (p =.003)]. While this issue was not 
observed in adipose tissue and a significant increase occurred only in 
TA B L E  2   Comparison of weight and dietary intake in interventional groups before and the end of treatment
Note: Data are presented as the mean ± SEM. * between two intervention and control group (HFD) by one- way ANOVA (Post hoc Tukey’s test); 
**Adjusted p- value for baseline amounts.
Abbreviations: CRD, calorie restriction diet; HFD, high- fat diet; SMD, standard mean differences with Cohen’s d.
Variables Weight before (gr) Weight after (gr) Adjusted SMD (CI 95%) Intake before (gr/day) Intake after (gr/day) Adjusted SMD (CI 95%)
Zn 467.5± 7.65 474.12 ± 8.91 -0.66(-1.65,0.34) 14.81±1.46 15.47±1.41 -0.11(-1.09,0.87)
Se 476.6 ± 8.14 423.25± 8.63*,** -2.35(-3.63,-1.02)* 15.03±2.48 13.25±2.39** -2.005(-3.21,-0.75)**
Zn + Se 472.4 ± 11.7 426.75± 11.92*,** -2.06(-3.28,-0.80)* 14.99±0.63 15.72±0.41 0.10(-0.88,1.08)
HFD 464.5 ± 4.92 496.25 ± 4.76 ------ 14.35±0.46 15.59±1.44 -----
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the group receiving selenium (p˂0.001) and the co- supplementation 
group (p =.001).
3.3 | The influence of zinc sulfate supplementation 
on selenium content and correlation between them
Along with increased zinc concentration, treatment with 15 mg/kg zinc 
sulfate significantly affected the serum level of selenium. Correlation 
analysis was performed to specify the association between Se and Zn 
in serum and tissue. A significant positive correlation between Se and 
Zn in serum and adipose tissue was observed in animals, respectively 
(r = 0.22, p- value = 0.038, r = 0.51, p- value = 0.0009).
3.4 | Effects of Se and Zn supplementation on anti- 
oxidative indices
As shown in Table 3, the levels of serum antioxidant enzymes 
GSH- Px and SOD were significantly increased in the Se and Zn + Se 
groups compared to HFD groups (p <.05). While in rats which re-
ceived Zn, serum levels of SOD showed an increasing trend that was 
slightly different from the significant level (p =.068) and GSH- Px did 
not show the difference between HFD groups. The level of SOD 
in adipose tissue showed a marked increase in all three interven-
tion groups compared to the control group, while the tissue levels 
of GSH- Px enzyme increased significantly only in Se and Zn + Se 
groups. Although an increase was observed in Zn group, it became 
marginally significant with a slight difference compared to the ref-
erence (p =.058). Our result showed that Se, Zn, and Zn + Se co- 
supplementation significantly lowered the MDA levels in serum and 
adipose tissue compared with the HFD group (p <.05). However, the 
group receiving co- administration of both the doses of Se and Zn 
showed a greater reduction in serum and tissue levels of MDA and 
remarkable increase in tissue levels of SOD that was considerable 
compared to groups which received Se or Zn supplementation alone 
(Figure 3).
3.5 | Effects of Se and Zn supplementation on 
leptin and anti- inflammatory markers
As shown in Figure 4, the serum level of leptin was significantly re-
duced in all treatment groups; the greatest decrease was observed in 
Zn group (p ˂  .001). Serum concentration of inflammatory markers in-
cluding TNF- α and IL- 6 was significantly decreased in all intervention 
F I G U R E  2   (a) Body weight in high- fat diet (HFD) group versus normal diet (ND) groups; (b) comparison of body weight in the Zn (n = 8), 
Se (n = 8), Zn + Se (n = 8), and HFD groups; (c) comparison of body weight changes in identical times in interventional groups with repeated 
measure ANOVA. Data shown as mean ± SD; *p <.05, **p <.001
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groups (p ˂ .001). The analysis showed that the reduction rate in the 
co- administration group was substantially higher than the other two 
intervention groups (Table 3).
3.6 | The role of leptin as a mediator
3.6.1 | Association of serum leptin level with 
selenium, zinc, anti- oxidative, and inflammatory indices
The association between serum concentration of leptin and se-
lenium, zinc, antioxidants, and inflammatory markers was evalu-
ated based on Pearson's correlation test in obese rats (n = 32). As 
shown in Table 4, a negative correlation between serum leptin and 
Se, Zn, GSH- Px, and SOD was observed. A significant positive cor-
relation was found between the level of MDA, TNF- α, IL- 6, and 
leptin levels.
3.6.2 | Assessing the effect of serum leptin as 
a mediator on improving the oxidative status and 
inflammatory parameters
Based on Baron and Kennyʼs method in defining a mediating factor, we 
first adjusted the effects of zinc, selenium, and co- supplementation 
on anti- oxidative and inflammatory factors for leptin (Figure 5). 
Then, we assessed the mediatory role of leptin on the anti- oxidative 
and anti- inflammatory effect of our interventions concerning all 
three conditions described in the method. In the present study, be-
cause all three conditions were met, leptin was identified as a media-
tor of Zn and Zn + Se co- supplementation effects on inflammatory 
markers (TNF- α and IL- 6) and MDA reduction. The results showed 
that the anti- inflammatory and anti- oxidative effects of zinc and the 
combination of zinc and selenium, although weakened, remained sig-
nificant after leptin adjusting in comparison to the HFD group. These 
effects were not observed for the level of GSH- Px and SOD. Leptin 
Variables Zn Se Zn + Se HFD
Leptin 4.70 ± 0.57 5.90 ± 0.83 5.21 ± 1.05 7.54 ± 1.29
P- Value* ˂0.001 0.048 0.001 - - - - - - 
SODS 34.45 ± 8.71 44.89 ± 19.79 55.75 ± 11.90 17.73 ± 7.05
p- Value* .057 .001 ˂.001 - - - - - - 
p- Value** .129 .065 .086
GPXS 22.68 ± 8.75 35.81 ± 14.47 40.54 ± 11.90 10.84 ± 4.23
p- Value* .224 ˂.001 ˂.001 - - - - - 
p- Value** .526 ˂.001 .101
SODT 39.89 ± 7.28 51.42 ± 14.21 70.84 ± 17.88 18.40 ± 4.13
p- Value* .013 ˂.001 ˂.001 - - - - - 
p- Value** .171 ˂.001 ˂.001
GPXT 20.97 ± 6.72 27.69 ± 9.37 28.66 ± 12.23 9.09 ± 5.10
p- Value* .058 .012 .007 - - - - - 
p- Value** .061 .003 .003
MDAS 3.01 ± 1.04 3.03 ± 0.97 2.01 ± 0.65 4.73 ± 0.88
p- Value* .013 .015 .001 - - - - - - 
p- Value** .021 ˂.001 .003
MDAT 159.07 ± 35.70 142.62 ± 37.77 121.36 ± 24.39 226.03 ± 52.30
p- Value* .023 .003 ˂.001 - - - - - - 
p- Value** .041 ˂.001 .001
TNF- αS 64.41 ± 7.38 74.49 ± 5.90 52.60 ± 6.20 126.95 ± 8.20
p- Value* ˂.001 ˂.001 ˂.001 - - - - - - 
p- Value** .005 ˂.001 .015
IL−6S 76.59 ± 6.67 76.25 ± 12.01 59.15 ± 10.57 107.54 ± 16.53
p- Value* ˂.001 ˂.001 ˂.001 - - - - - - 
p- Value** .001 ˂.001 .007
Note: Data are shown as the mean ± SD; * P- value is indicated versus HFD group by one- way 
ANOVA(Post hoc Tukey's test); ** Adjusted for leptin. HFD: high- fat diet. S: measurement is 
indicated in serum level. T: measurement is indicated in WAT.
Abbreviations: GPX, Glutathione peroxidase; IL- 6, Interleukin- 6; MDA, Malondialdehyde; SOD, 
Superoxide dismutase; TNF- α, tumor necrosis factor- α.
TA B L E  3   Comparison of anti- oxidative 
and inflammatory indices in interventional 
groups
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also did not meet the required conditions to consider as a mediator 
for the anti- inflammatory and anti- oxidative effects of selenium.
4  | DISCUSSION
The present study evaluated the effects of zinc and selenium sup-
plementation, alone and in combination, on obesity (weight, food 
intake, antioxidant status, and inflammatory markers). Also, for the 
first time, the synergistic effects of the combination of these two 
supplements on the complications associated with obesity were 
examined. On the other hand, the role of leptin as a mediator in 
the effects of zinc and selenium was investigated. The results 
of the present study showed that Se supplementation improves 
weight control in the obesity situation. In fact, rats in Se group lost 
about 11 percent of their weight before the intervention. The find-
ings of the studies by Cavedon et al. (2020) and Zhang et al. (2018) 
were in line with ours. Also, in another experimental study, so-
dium selenite moderately attenuated the increased body weight 
of HFD- fed mice (Nido et al., 2016). On the other hand, selenium 
intake reduced dietary intake in adjusted model in our research. 
However, there are disagreements in previous studies on the ef-
fects of selenium on weight and food intake (Falk et al., 2019; 
Mechlaoui et al., 2019; Nido et al., 2016). These contradictions flow 
from to the utilization of various sorts of selenium supplements 
or different doses in combination with other materials. This is in-
controvertible fact that the consequences of selenium on weight 
are strongly dose- dependent. Selenium in high doses has been 
shown to be ready to even cause weight gain (Zeng et al., 2012). 
However, the selenium- induced weight loss observed in this study 
may be due to reduced dietary intake, as well as other factors like 
the effects of selenium on the genes involved in the mechanisms 
related to thermogenesis (Steinbrenner, 2013) or the effect on 
thyroid hormone activity (Guarino et al., 2018; Mahmoodianfard 
et al., 2015). Unfortunately, in the present study, the mentioned 
mechanisms have not been investigated and this is proposed for 
future studies. Unlike selenium, zinc supplementation showed an 
increasing trend in both weight and food intake but was not sta-
tistically significant. This results revealed that Zn supplementation 
ameliorated the increased body weight of HFD- fed rats, although 
the difference was not considerable. There is controversy about 
the effect of zinc on weight and dietary intake in literature; 
however, several studies have been consistent with our results 
(Mousavi et al., 2018; Tallman & Taylor, 2003; Wang et al., 2012). 
Meanwhile, given the background on the association between 
zinc and weight, we measured the correlation between serum 
F I G U R E  3   Comparison of (a) SOD concentration in serum, (b) GSH- Px concentration in serum, (c) MDA concentration in serum in 
interventional groups; Data shown as mean ± SD; *p <.05, **p <.001
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and tissue levels of zinc and animal weight and again found no 
significant relationship. Consistent with the newest meta- analysis, 
it is still impossible to succeed in a conclusive results about the 
effect of zinc on weight (Abdollahi et al., 2020). About increasing 
food intake by consuming zinc, it can be considered that obesity 
is generally associated with zinc deficiency and its effects, one 
among which is anorexia, so with the administration of zinc and 
improvement of deficiency, anorexia disappears and food intake 
increases (Marreiro et al., 2006) that literature was consensus with 
our finding (Ghaemmaghami et al., 2010; Narjes Zare et al., 2020). 
F I G U R E  4   Comparison of (a) TNF- α concentration in serum, (b) IL- 6 concentration in serum, (c) leptin concentration in serum in groups of 
treatment; Data shown as mean ± SD; *p <.05, **p <.001
variable Zn Se GPX SOD MDA TNF- α IL−6
r −.36 −.31 −.487 −.484 .493 .695 .655
p- Value .021 .048 .006 .007 .20 ˂.001 ˂.001
Note:: Coefficients (r) and p values are calculated using Pearson's correlation analysis.
Abbreviations: GPX, Glutathione peroxidase; IL- 6, Interleukin- 6; MDA, Malondialdehyde; SOD, 
Superoxide dismutase; TNF- α, tumor necrosis factor- α.
TA B L E  4   Correlation between serum 
leptin level and level of Zn, Se, anti- 
oxidative, and inflammatory indices
F I G U R E  5   Diagram of leptin role as a 
mediator
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Marked weight loss but less than the selenium group was seen 
in the combination group (9.5% of their weight before the inter-
vention), and its food intake was not different from the control 
group. Perhaps the reason that the combination of the two supple-
ments is less effective than selenium is the positive effects of zinc 
on weight and appetite in this research. So that, in the selenium 
group, significant weight loss was observed after the end of the 
first two weeks of the intervention and continued until the end, 
while in the combination group, a significant difference was ob-
served from the middle of the intervention period.
In this research, a significant increase in serum and tissue levels 
of zinc and selenium was observed through supplementation. Also, 
based on the obtained results, it seems that zinc administration in-
creases the level of Se due to the positive correlation shown with 
levels of this metal. In the study by Skalny et al. (Skalny et al., 2015), 
which was performed on rats, zinc supplementation increased se-
lenium levels, which confirms the results of the current study. 
However, in Zn + Se group, although the selenium levels were in-
creased significantly more than the control, but in compare to the Se 
and Zn groups, this did not happen.
In the same sense with the current findings, a wide variety of 
animal and human researches have shown an increase in SOD and 
GSH- Px activity and decrease in MDA, TNF- α, and IL- 6 with zinc and 
selenium intake (Asri- Rezaei et al., 2015; El- Demerdash & Nasr, 2014; 
Hasani et al., 2019; Nido et al., 2016; Prasad, 2014; Tomas- Sanchez 
et al., 2018; Zhang et al., 2018). Of course, in our study, supplemen-
tation with zinc despite increasing the amount of GSH- Px compared 
to the high- fat group, but it was marginally significant in WAT that 
one of the reasons could be the low sample size, which affects the 
amount of P. value or power of statistical tests. To confirm this, we 
calculated the standardized mean differences, and at this stage, 
the effects of zinc on GSH- Px became meaningful [SMD: 1.51, CI 
(0.36– 2.62)]. However, the difference was insignificant in the serum 
concentration of GSH- Px (β = 0.67). Furthermore, a remarkable in-
crease in SOD activity and considerable decrease in MDA, TNF- α, 
and IL- 6 were observed with Se and Zn co- supplementation com-
pared with individual administration. The synergistic effect of Se 
and Zn could be attributed to the improvement of anti- oxidative and 
inflammatory indices. It should be noted that concomitant zinc and 
selenium deficiency is frequently observed in various pathological 
conditions (Çavdar et al., 2009; Cirino Ruocco et al., 2018; Khalili 
et al., 2008) as well as in healthy (Ghayour- Mobarhan et al., 2005) 
and obese individuals (Brighenti et al., 1987). Based on these facts, 
it can be determined that there is a strong association between se-
lenium and zinc homeostasis, which has been investigated and con-
firmed in various fundamental studies (Blessing et al., 2004; Feroci 
et al., 2005). Previous researches have determined the possibility of 
mutual influence and the potential for interactions between zinc and 
selenium in the case of supplementation (Guo et al., 2013). As in our 
study, we found that zinc intake alone can increase selenium levels. 
Putting these points together, it seems to be possible to emphasize 
the strong and two- way association between Se and Zn as well as 
the synergistic effects of them in combination.
Our data indicate that Zn, Se, and co- administration attenuated 
the elevation of leptin following HFD- induced obesity. The strongest 
effect and decrease in leptin was seen in the Zn group compared 
to other intervention groups. Leptin resistance develops in obesity 
and causes hyperleptinemia. It is correlated with proinflammatory 
responses and increased levels of inflammatory markers observed 
in obesity. On the other hand, chronic inflammation caused by pro-
moting proinflammatory cytokines such as IL- 6 and TNF- a may inter-
fere with leptin receptor signaling and impaired leptin function. Also, 
inflammatory cytokines (IL- 6 and TNF- a) increase leptin production 
by adipose tissue. Increased leptin resistance is associated with high 
levels of free fatty acids may play a role in reducing fat oxidation 
in insulin- sensitive organs and lead to fat accumulation (Izquierdo 
et al., 2019; Paz- Filho et al., 2012). The latest systematic review on 
the role of leptin on inflammation and obesity is consistent with our 
findings (Pérez- Pérez et al., 2020). According to previous in vitro 
study, NaSeO4 exposure can inhibit adipocyte differentiation, sup-
pressing PPAR, C/EBP, and leptin gene expression in 3T3- L1 pread-
ipocytes (Kim & Kim, 2018). In a study by Cavedon et al., selenium 
supplementation for three months in obese individuals significantly 
reduced leptin levels that support our finding about selenium effect.
Based on literature, there is a complicate association between 
zinc and leptin in obesity conditions. The results of these researches 
revealed that zinc deficiency in obesity further increases the pro-
duction and secretion of leptin; in contrast, zinc supplementation 
can reduce elevated levels of leptin and can be effective in improve-
ment of the leptin resistance which occurs following obesity. Zinc 
can exert this reduction by interfering with the mechanisms in-
volved in the production and secretion of leptin (Chen et al., 2000; 
Liu et al., 2013; Tallman & Taylor, 2003). Since our findings showed 
that the reduction of inflammatory markers and lipid peroxidation 
is related to a decrease in leptin, a hypothesis came to us that some 
of the anti- inflammatory and anti- oxidative effects of zinc may have 
been mediated by leptin. So, we performed the mediator analysis 
and it revealed that leptin acts as a mediator in reducing proinflam-
matory and oxidative markers. Consistent with results of the present 
study, in review article by Baltaci et al. revealed that there are com-
plex and critical relationships between zinc and leptin in terms of 
both regulation food intake and cellular immune responses, but zinc 
may play an important role in regulating the effects of leptin (Baltaci 
& Mogulkoc, 2012). To the best of our knowledge, few studies have 
investigated the synergistic effect of Se and Zn co- supplementation 
and on anti- oxidative and anti- inflammatory events and mediation 
role of leptin on the effects of zinc in obesity. There are variety of 
unknown mechanisms in this area. Therefore, more accurate evalua-
tions are suggested to achieve a conclusive results.
5  | CONCLUSIONS
In conclusion, the results of the present study revealed that selenium 
and zinc administration are beneficial in weight loss and inhibition 
of weight gain due to HFD- induced obesity. Supplementation with 
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the combination of selenium and zinc has stronger effects on reduc-
ing oxidative stress and chronic inflammation observed in obesity, 
which may suggest a synergistic effect of these two metals com-
pared to receiving each individual. Also, leptin can act as a mediator 
in the effects of zinc on inflammatory factors and lipid peroxidation. 
However, more research is needed to find out precise mechanisms.
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